Expression and mutation analyses of MKK4, a candidate tumour suppressor gene encoded by chromosome 17p, in human gastric adenocarcinoma

European Journal of Cancer

Volumn 38, Issue 15, 2002, Pages 2048-2057

  Chae, K S ^a   Ryu, B K ^a   Lee, M G ^a   Byun, D S ^a   Chi, S G ^a  

^a Kyung Hee University Hospital   (South Korea)

Author keywords

17p; Gastric cancer; Loss of heterozygosity; MKK4; Processed pseudogene; TP53; Tumour suppressor gene

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE KINASE; PROTEIN;

ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; BENIGN TUMOR; CANCER GRADING; CANCER STAGING; CARCINOGENESIS; CELL ASSAY; CELL LINE; CHROMOSOME 17P; CODING; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; GENETIC ANALYSIS; GENETIC CODE; GENETIC TRANSCRIPTION; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOGENE; SEQUENCE HOMOLOGY; STOMACH; STOMACH ADENOCARCINOMA; STOMACH CARCINOMA; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

ADENOCARCINOMA; AMINO ACID SEQUENCE; BASE SEQUENCE; BLOTTING, WESTERN; CHROMOSOMES, HUMAN, PAIR 17; GENE EXPRESSION; GENES, TUMOR SUPPRESSOR; HUMANS; LOSS OF HETEROZYGOSITY; MAP KINASE KINASE 4; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MUTATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PSEUDOGENES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0036791953     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(02)00147-8     Document Type: Article

References (36)

1. Hunter T. A thousand and one protein kinases. Cell. 50:1987;823-829.
2. Hunter A., Cooper J.A. Protein-tyrosine kinases. Annu. Rev. Biochem. 54:1985;897-930.
3. Taylor S.S., Knighton D.R., Zheng J., Ten Eyck L.F., Sowadski J.M. Structural framework for the protein kinase family. Annu. Rev. Cell. Biol. 8:1992;429-462.
4. Edelman A.M., Blumenthal D.K., Krebs E.G. Protein serine/threonine kinases. Annu. Rev. Biochem. 56:1987;567-613.
5. Robinson D., He F., Pretlow T., Kung H.J. A tyrosine kinase profile of prostate carcinoma. Proc. Natl. Acad. Sci. USA. 93:1996;5958-5962.
6. Lin W., Kao H.W., Robinson D., Kung H.J., Wu C.W., Chen H.C. Tyrosine kinases and gastric cancer. Oncogene. 19:2000;5680-5689.
7. Kameda T., Yasui W., Yoshida K.et al. Expression of ERBB2 in human gastric carcinomas. relationship between p185ERBB2 expression and the gene amplification Cancer Res. 50:1990;8002-8009.
8. Tsugawa K., Yoemura Y., Hirono Y.et al. Amplification of the c-met, c-erbB-2 and epidermal growth factor receptor gene in human gastric cancers. correlation to clinical features Oncology. 55:1998;475-481.
9. Wu C.W., Li A.F.Y., Chi C.W.et al. Human gastric cancer kinase profile and prognostic significance of MKK4 kinase. Am. J. Pathology. 56:2000;2007-2015.
10. Cuenda A. Mitogen-activated protein kinase kinase 4 (MKK4). Int. J. Biochem. Cell Biol. 32:2000;581-587.
11. Derijard B., Raingeaud J., Barret T.et al. Independent human MAP kinase signal transduction pathways defined by MEK and MKK isoforms. Science. 267:1995;682-685.
12. Derijard B., Hibi M., Wu I.et al. JNK1. a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain Cell. 76:1994;1025-1037.
13. Lin A., Minden A., Martinetto H. Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2. Science. 286:1995;286-290.
14. Teng D.H.F., Perry 3r W.L., Hogan J.K.et al. Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor. Cancer Res. 57:1997;4177-4182.
15. Su G.H., Hilgers W., Shekher M.C.et al. Alterations in pancreatic, biliary, and breast carcinomas support MKK4 as a genetically targeted tumor suppressor gene. Cancer Res. 58:1998;2339-2342.
16. Yoshida B.A., Dubauskas Z., Chekmareva M.A., Christiano T.R., Stadler W.M., Rinker-Schaeffer C.W. Mitogen-activated protein kinase 4/stress-activated protein kinase/erk kinase 1 (MKK4/SEK1), a prostate cancer metastasis suppressor gene encoded by human chromosome 17. Cancer Res. 59:1999;5483-5487.
17. Kim H.L., Vander Griend D.J., Yang X.et al. Mitogen-activated protein kinase kinase 4 metastasis suppressor gene expression is inversely related to histological pattern in advancing human prostatic cancers. Cancer Res. 61:2001;2833-2837.
18. Sano T., Tsujino T., Yoshida K.et al. Frequent loss of heterozygosity on chromosome 1q, 5q, and 17p in human gastric carcinomas. Cancer Res. 51:1991;2926-2931.
19. Yustein A.S., Harper J.C., Petroni G.R., Cummings O.W., Moskaluk C.A., Powell S.M. Allelotype of gastric adenocarcinoma. Cancer Res. 59:1999;1437-1441.
20. Tahara E. Genetic alterations in human gastrointestinal cancers. The application of molecular diagnosis. Cancer (Supplement). 75:1995;1410-1417.
21. Tamura G., Ogaswara S., Nishizuka S.et al. Two distinct regions of deletion on the long arm of chromosome 5 in differentiated adenocarcinomas of the stomach. Cancer Res. 56:1996;612-615.
22. Uchino S., Tsuda H., Noguchi M.et al. Frequent loss of heterozygosity at the DCC locus in gastric cancer. Cancer Res. 52:1992;3099-3102.
23. Kastury K., Baffa R., Druck T.et al. Potential gastrointestinal tumor suppressor locus at the 3p14.2 FRA3B site identified by homozygous deletions in tumor cell lines. Cancer Res. 56:1996;978-983.
24. Choi S.W., Park S.W., Lee K.Y., Kim K.M., Chung Y.J., Rhyu M.G. Fractional allelic loss in gastric carcinoma correlates with growth patterns. Oncogene. 17:1998;2655-2659.
25. Rhyu M., Park W., Jung Y., Choi S., Meltzer S. Allelic deletions of MCC/APC and p53 are frequent late events in human gastric carcinomas. Gastroenterology. 106:1994;1584-1588.
26. Kim J.H., Takahashi T., Chiba I.et al. Occurrence of p53 gene abnormalities in gastric carcinoma tumors and cell lines. J Natl Cancer Inst. 83:1991;938-943.
27. Yokozaki H. Molecular characteristics of eight gastric cancer cell lines established in Japan. Pathol Int. 50:2000;767-777.
28. Tamura G., Kihana T., Nomura K., Terada M., Sugimura T., Hirohashi S. Detection of frequent p53 gene mutations in primary gastric cancer by cell sorting and polymerase chain reaction single-strand conformation polymorphism analysis. Cancer Res. 51:1991;3056-3058.
29. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid-guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
30. Chi S.G., Chang S.G., Lee S.J., Lee C.H., Kim J.I., Park J.H. Elevated and biallelic expression of p73 is associated with progression of human bladder cancer. Cancer Res. 59:1999;2791-2793.
31. Chi S.G., Kim H.J., Park B.J.et al. Mutational abrogation of the PTEN/MMAC1 gene in gastrointestinal polyps in patients with Cowden disease. Gastroenterology. 115:1998;1084-1089.
32. Chi S.G., deVere White R.W., Meyers F.J., Siders D., Lee F., Gumerlock P.H. p53 in prostate. frequent expressed transition mutations J. Natl. Cancer Inst. 86:1994;926-933.
33. Gumerlock P.H., Chi S.G., Shi X.B.et al. p53 abnormalities in primary prostate cancer. single-strand conformation polymorphism analysis of complementary DNA in comparison with genomic DNA J. Natl. Cancer Inst. 89:1997;66-71.
34. Hahn S.A., Seymour A.B., Hoque A.T.M.S.et al. Allelotype of pancreatic adenocarcinoma using a xenograft model. Cancer Res. 55:1995;4670-4675.
35. Bradley J.F., Rothberg P.G. Processed pseudogene from the von Hippel-Lindau disease gene is located on human chromosome 1. Diagn. Mol. Pathol. 8:1999;101-106.
36. Dahia P.L.M., FitzGerald M.G., Zhang X.et al. A highly conserved processed PTEN pseudogene is located on chromosome band 9p21. Oncogene. 16:1998;2403-2406.